Salvage PRRT With 177Lu-Dota-Octreotate in Extensively Pretreated Patients With Metastatic Neuroendocrine Tumor (NET): Dosimetry, Toxicity, Efficacy, and Survival
BMC Cancer - United Kingdom
doi 10.1186/s12885-019-6000-y
Full Text
Open PDFAbstract
Available in full text
Date
August 8, 2019
Authors
Publisher
Springer Science and Business Media LLC